Company Filing History:
Years Active: 2006
Title: Praveen Kumar: Innovator in Mass Spectrometry
Introduction
Praveen Kumar is a notable inventor based in Santa Clara, CA. He has made significant contributions to the field of mass spectrometry, particularly in the quantification of chemical mixture components. His innovative approach has the potential to enhance research in proteomics and metabolomics.
Latest Patents
Praveen Kumar holds a patent for "Mass spectrometric quantification of chemical mixture components." This patent describes a method for obtaining relative quantitative information about components of chemical or biological samples from mass spectra. The technique involves normalizing the spectra to yield peak intensity values that accurately reflect the concentrations of the responsible species. A normalization factor is computed from peak intensities of inherent components whose concentration remains constant across a series of samples. This method allows for the estimation of relative concentrations of components occurring in different samples from the normalized peak intensities. Unlike conventional methods, it does not require internal standards or additional reagents. This innovation is particularly useful for differential phenotyping in proteomics and metabolomics research, where molecules varying in concentration across samples are identified. These identified species may serve as biological markers for disease or response to therapy.
Career Highlights
Praveen Kumar is currently employed at PPD Biomarker Discovery Sciences, LLC, where he continues to advance his research in mass spectrometry. His work is instrumental in developing methods that improve the accuracy and efficiency of chemical analysis.
Collaborations
Praveen collaborates with esteemed colleagues, including Christopher Hank Becker and Curtis A Hastings, who contribute to his research endeavors.
Conclusion
Praveen Kumar's innovative work in mass spectrometry exemplifies the impact of modern inventions on scientific research. His contributions are paving the way for advancements in understanding biological markers and their implications in health and disease.